Byetta Injection
Product Images NDC 0310-6512

116 FDA label images from Astrazeneca Pharmaceuticals Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 116 technical images submitted to the FDA as part of the official labeling for Byetta (NDC 0310-6512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Byetta 01)

Figure 1 (Byetta 01)
A line graph showing insulin secretion rate (pmol/kg/min) over time (minutes) split into first-phase and second-phase insulin responses. The graph compares responses after an IV glucose bolus at 0 minutes in three groups: BYETTA (Type 2 Diabetes, N=13), Glucose (Type 2 Diabetes, N=13), and Saline (Healthy, N=12). Error bars indicate variability among participants.*
FDA Label Image

Figure 2 (Byetta 02)

Figure 2 (Byetta 02)
A line graph comparing plasma glucose levels (mg/dL) over time (minutes) after subcutaneous injection of Byetta (exenatide) versus placebo. The graph includes data points from 0 to 240 minutes, showing a decrease in plasma glucose for Byetta recipients and a higher trend for placebo. Markers indicate administration of subcutaneous injection and standardized breakfast timing.*
FDA Label Image

Figure 3 (Byetta 03)

Figure 3 (Byetta 03)
This image contains two line graphs depicting the pharmacodynamic effects of Byetta (exenatide) injection compared to placebo over time. The top graph shows serum insulin levels (µU/mL) increasing sharply after injection with Byetta, while placebo remains relatively steady. The bottom graph displays plasma glucose levels (mg/dL) decreasing markedly after Byetta injection versus a slower decline with placebo, both measured over an 8-hour period.*
FDA Label Image

Byetta Pen 5mcg (Image 02)

Byetta Pen 5mcg (Image 02)
Byetta 250 mcg/mL subcutaneous injection pen device shown in blue and orange colors. The pen is prefilled, intended for subcutaneous use, and labeled with the number 5 near the injection button. Manufactured by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Byetta Parts (Byetta 05)

Byetta Parts (Byetta 05)
Illustration of the Byetta pen parts for exenatide 250 mcg/mL injection by AstraZeneca Pharmaceuticals LP. The pen components shown include the blue pen cap, cartridge containing Byetta liquid, label, dose window displaying a dose of 5, dose knob, and injection button. The image serves to identify the parts of the Byetta subcutaneous injection pen device.*
FDA Label Image

Penneedleparts (Byetta 06)

Penneedleparts (Byetta 06)
Illustration diagram showing parts of a pen needle (outer needle shield, inner needle shield, needle, paper tab) with a note that pen needles are not included. The diagram also includes dose window symbols used for injection dosing: ready to pull dose knob out, ready to turn to dose position, ready to inject 5 mcg, and dose knob pushed in and ready to reset.*
FDA Label Image

Check The Pen (Image 03)

Check The Pen (Image 03)
An instructional illustration showing a person holding an orange Byetta injection pen and removing the blue protective cap, demonstrating preparation of the exenatide 250 mcg/mL subcutaneous injection pen by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Check Betta Cartidge (Image 04)

Check Betta Cartidge (Image 04)
An instructional diagram showing a close-up of a hand holding an orange Byetta (exenatide) 250 mcg/mL subcutaneous injection pen. The image demonstrates the step of removing the protective cap from the injection pen prior to use.*
FDA Label Image

Remove Paper From Needle (Byetta 09)

Remove Paper From Needle (Byetta 09)
An instructional illustration showing hands preparing a Byetta (exenatide) 250 mcg/mL subcutaneous injection pen. The image depicts one hand holding the pen while the other hand is twisting or attaching part of the pen, likely illustrating the process of preparing the pen for injection.*
FDA Label Image

Pull Off Outer Needle (Byetta 10)

Pull Off Outer Needle (Byetta 10)
An instructional illustration showing a person removing a protective cap from the needle of a prefilled syringe injection pen, likely for subcutaneous use. The syringe contains medication, and the image visually guides on needle preparation before injection.*
FDA Label Image

Pull Off Inner Needle Shield (Byetta 11)

Pull Off Inner Needle Shield (Byetta 11)
An instructional illustration showing a close-up of a hand removing a purple protective cap from the needle of a syringe. This image is likely related to the preparation of Byetta (exenatide) 250 mcg/mL subcutaneous injection for use.*
FDA Label Image

Check The Dose Window (Image 05)

Check The Dose Window (Image 05)
Byetta 250 micrograms per milliliter subcutaneous injection pen showing a close-up of the dosage window indicating a dose of 5. The device is primarily orange with a small rectangular window displaying the dose number. Labeler is AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Pull Dose Knob Out (Image 06)

Pull Dose Knob Out (Image 06)
Illustration showing the injection tip of a Byetta 250 mcg/mL pen injector. The image highlights the injection interface with a numbered label '5' and a finger pressing the top mechanism, demonstrating the administration process of the subcutaneous injection.*
FDA Label Image

Turn Dose Knob (Image 07)

Turn Dose Knob (Image 07)
An instructional illustration showing a close-up of a hand twisting the orange cap of a Byetta (exenatide) subcutaneous injection pen, highlighting the dose selection window displaying the number 5.*
FDA Label Image

Right Facing Arrow (Image 51)

FDA Label Image

Right Facing Arrow (Image 52)

FDA Label Image

Up Facing Arrow (Image 41)

Up Facing Arrow (Image 41)
Byetta 250 mcg/mL injection vial label showing the drug name, exenatide, as the active ingredient. The subcutaneous injection is provided in a single-dose vial with 1.2 mL volume. The label includes the AstraZeneca Pharmaceuticals LP logo and regulatory information.*
FDA Label Image

Number Five (Image 56)

Number Five (Image 56)
Byetta 250 mcg/mL injection pen. The image shows a white and purple prefilled pen device designed for subcutaneous administration of exenatide. The pen is labeled with the brand name Byetta and has a dosage strength of 250 micrograms per milliliter. AstraZeneca Pharmaceuticals LP is the labeler.*
FDA Label Image

5 (Byetta 17)

5 (Byetta 17)
Byetta 250 mcg/mL injection label for subcutaneous use. The image shows a vial label with the proprietary name Byetta and the generic name exenatide. It is manufactured by AstraZeneca Pharmaceuticals LP. The label includes dosage strength information and appears designed for prescription use.*
FDA Label Image

Point Needle Away From You (Byetta 18)

Point Needle Away From You (Byetta 18)
An illustration showing a hand holding a Byetta injection pen pre-filled with exenatide 250 mcg/mL for subcutaneous use, demonstrating the injection device ready for administration.*
FDA Label Image

Push And Hold (Byetta 19)

Push And Hold (Byetta 19)
An instructional illustration showing a hand holding a Byetta injection pen close to the skin, with an arrow indicating the injection site and an icon indicating to hold for 5 seconds. This diagram demonstrates proper subcutaneous injection technique for Byetta (exenatide) 250 mcg/mL injection by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Pen Preparation (Byetta 20)

Pen Preparation (Byetta 20)
Byetta 250 mcg/mL injection, subcutaneous, proprietary label showing a close-up of the dial window set to dose 5. The image depicts part of the pen device used for administering exenatide, labeled by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Triangle1 (Image 53)

Triangle1 (Image 53)
Byetta 250 mcg/mL injection vial label, featuring the proprietary name Byetta and the generic name exenatide. The label is primarily blue with a clear measurement scale on the vial showing 0 to 0.2 mL volume. The product is manufactured by AstraZeneca Pharmaceuticals LP for subcutaneous use.*
FDA Label Image

Turn Dose Window (Byetta 33)

Turn Dose Window (Byetta 33)
An instructional illustration showing a close-up of a Byetta (exenatide) injection pen. The image focuses on the dial mechanism set to the number 5 and a finger pressing or turning the top of the pen, suggesting dose selection or injection preparation steps for subcutaneous administration.*
FDA Label Image

Arrow Pointing Right (Step E Arrow 5mcg)

Arrow Pointing Right (Step E Arrow 5mcg)
Byetta 250 mcg/mL injection pen packaging label, subcutaneous use. The label shows the brand name Byetta and indicates the solution concentration as 250 micrograms per milliliter. It is a human prescription drug manufactured by AstraZeneca Pharmaceuticals LP. The packaging is a small paper carton primarily in white, blue, and orange colors.*
FDA Label Image

Check Pen Label (Byetta 22)

Check Pen Label (Byetta 22)
Instructional image showing a person holding and preparing to assemble a Byetta 250 mcg/mL injection pen for subcutaneous use. Hands are depicted with one hand holding the pen and the other hand holding the pen cap being removed in preparation for injection.*
FDA Label Image

Check Cartridge (Byetta 23)

Check Cartridge (Byetta 23)
An instructional illustration showing a hand holding a Byetta (exenatide) 250 mcg/mL subcutaneous injection pen. The image highlights the injection pen preparation or administration step with a blue arrow indicating a part of the device to interact with.*
FDA Label Image

Remove Paper Tab (Image 08)

Remove Paper Tab (Image 08)
An instructional illustration showing how to attach or remove a needle cover on a Byetta injection pen. The image depicts hands holding the pen and twisting the needle cover in a clockwise and counterclockwise direction as indicated by the blue arrows.*
FDA Label Image

Pull Off Needle Shield (Image 09)

Pull Off Needle Shield (Image 09)
An instructional illustration showing a hand holding a needle cap, positioned to remove it from a syringe. The syringe is prefilled, with a purple needle visible at the tip. The image demonstrates the step of preparing a subcutaneous injection, likely for Byetta (exenatide) 250 mcg/mL.*
FDA Label Image

Pull Off Inner Needle Shield And Throw Away (Image 10)

Pull Off Inner Needle Shield And Throw Away (Image 10)
An instructional illustration showing a person's hand attaching a purple needle cap to a syringe, demonstrating preparation for subcutaneous injection.*
FDA Label Image

Check Window Dose (Byetta 27)

Check Window Dose (Byetta 27)
Byetta 250 mcg/mL subcutaneous injection pen showing a close-up of the dose selector window displaying the dose number 5. The pen is orange with white ends and is produced by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Pull Dose Knob (Byetta 28)

Pull Dose Knob (Byetta 28)
An instructional diagram showing a close-up of a Byetta injection pen with an arrow pointing to the injection button and the dose number window displaying the number 5. The figure demonstrates how to use the pen for subcutaneous injection.*
FDA Label Image

Turn Knob Away (Image 11)

Turn Knob Away (Image 11)
An instructional diagram showing a close-up of a Byetta injection pen with a thumb turning a dial to select the dose '5'. Blue arrows indicate the direction for adjusting the dose on the 250 mcg/mL subcutaneous injection device by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Arrow Pointing Right (Step 3 Arrow 5mcg)

Arrow Pointing Right (Step 3 Arrow 5mcg)
Byetta 250 mcg/mL injection carton labeled with the brand and generic name exenatide. The label indicates it is a human prescription drug for subcutaneous use. The manufacturer is AstraZeneca Pharmaceuticals LP. The package includes product identification and strength information in a vertical, multi-color design.*
FDA Label Image

Arrow Pointing Right (Step 3 Arrow Dose 5mcg)

Arrow Pointing Right (Step 3 Arrow Dose 5mcg)
Byetta 250 mcg/mL injection pen carton and pen device, a subcutaneous injection pharmaceutical product containing exenatide. The packaging includes the brand name, dosage strength, and manufacturer, AstraZeneca Pharmaceuticals LP. The carton also displays usage instructions and vial graphics, and the device is a multi-dose pen for self-administration.*
FDA Label Image

Arrow Pointing Up (Pull Dos 5mcg)

Arrow Pointing Up (Pull Dos 5mcg)
Byetta 250 mcg/mL injection carton and pen device label showing the brand name Byetta and active ingredient exenatide. The packaging is white with red accents, indicating the subcutaneous injection dosage form. The labeler AstraZeneca Pharmaceuticals LP is visible on the packaging.*
FDA Label Image

5 (Turn Dos 5mcg)

5 (Turn Dos 5mcg)
Byetta 250 mcg/mL injection label for subcutaneous use. The label prominently displays the brand name Byetta and the strength of 250 mcg/mL. It is manufactured by AstraZeneca Pharmaceuticals LP. The product is intended for human prescription use and comes in an injection form.*
FDA Label Image

5 (Note 5mcg)

5 (Note 5mcg)
Byetta 250 mcg/mL injection carton and pen device label by AstraZeneca Pharmaceuticals LP. The subcutaneous injection product contains exenatide as the active ingredient in a 1.2 mL single-use/pen format. The packaging shows dosing instructions, storage information, and branding details.*
FDA Label Image

Grip Pen Firmly (Byetta 30)

Grip Pen Firmly (Byetta 30)
Photograph showing a person administering a subcutaneous injection using a Byetta injection pen. The image depicts hand positioning and injection technique for the 250 microgram per milliliter exenatide injection by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Push And Hold (Byetta 31)

Push And Hold (Byetta 31)
An instructional illustration showing a person holding a Byetta injection pen with the label strength 250 mcg/mL visible. The image includes a labeled circle indicating 5 seconds, suggesting a step in the injection process. An arrow points to the injection pen's button or end to highlight pressing or activating action for Byetta, exenatide subcutaneous injection from AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Injection Is Complete (Byetta 32)

Injection Is Complete (Byetta 32)
Byetta 250 micrograms per milliliter injection packaging label segment showing a blue and orange design with the number 5 prominently displayed and a small black arrow symbol centered within a clear plastic window.*
FDA Label Image

Arrow Pointing Up (Injection Arrow)

Arrow Pointing Up (Injection Arrow)
Byetta 250 microgram/mL injection carton and pen injector kit labeled for subcutaneous use. The label identifies the active ingredient as exenatide and shows the AstraZeneca Pharmaceuticals LP labeler. The packaging includes the pen injector device and mentions the Dosage strength clearly on the carton.*
FDA Label Image

Turn Dose 5mcg (Turn Dose 5mcg 01)

Turn Dose 5mcg (Turn Dose 5mcg 01)
An instructional illustration showing a close-up of a finger pressing the dose button on the end of a Byetta injection pen, highlighting the number 5 dose setting and the rotation direction indicated by a blue arrow.*
FDA Label Image

Arrow Pointing Right (Reset 5mcg Arrow)

Arrow Pointing Right (Reset 5mcg Arrow)
Byetta 250 microgram per mL injection carton label, a subcutaneous prescription drug containing exenatide. The label displays the brand and generic names, strength, dosage form, and AstraZeneca Pharmaceuticals LP as the labeler. Packaging includes warnings and usage instructions typical for an injectable medication.*
FDA Label Image

Carefully Put The Outer Needle (Byetta 34)

Carefully Put The Outer Needle (Byetta 34)
An instructional illustration showing a subcutaneous injection pen with an orange cap, a clear barrel marked with dosage measurements, and a white protective cap pointed at by a blue arrow, indicating removal or attachment.*
FDA Label Image

Unscrew The Needle (Byetta 35)

Unscrew The Needle (Byetta 35)
An illustration showing a hand holding a Byetta (exenatide) injection pen with the cap removed, demonstrating preparation or use of the subcutaneous injection device. The Byetta pen is orange with a label displaying the product name and dosage.*
FDA Label Image

Throw Away Needles (Byetta 36)

Throw Away Needles (Byetta 36)
Byetta 250 mcg/mL injection in a pre-filled pen device for subcutaneous use. The device is labeled with dosing information and the AstraZeneca Pharmaceuticals LP logo. The image shows a hand holding the pen, emphasizing its user-friendly design for self-administration.*
FDA Label Image

Triangle2 (Injection Complete Arrow)

Triangle2 (Injection Complete Arrow)
Byetta 250 mcg/mL Injection single-dose pen carton. The label shows the brand name Byetta and active ingredient exenatide, indicating a subcutaneous injection dosage form. The packaging is primarily white with text and design elements in teal and gray. AstraZeneca Pharmaceuticals LP is listed as the labeler.*
FDA Label Image

Where To Inject Byetta (Byetta 37)

Where To Inject Byetta (Byetta 37)
An illustration showing injection sites for Byetta (exenatide) 250 mcg/mL subcutaneous injection. Front view highlights the abdomen and front thighs as injection areas. Back view highlights the upper arms as injection sites.*
FDA Label Image

Rightarrow1 (Image 54)

Rightarrow1 (Image 54)
Byetta 250 mcg/mL injection single-dose pen, a subcutaneous human prescription drug by AstraZeneca Pharmaceuticals LP. The image displays a box with the product name, strength, dosage form, and labeler information clearly visible in blue and white packaging.*
FDA Label Image

Plus Sign (Pull Out Arrow)

Plus Sign (Pull Out Arrow)
Byetta 250 microgram per milliliter subcutaneous injection carton and glass vial packaging. The product is labeled as exenatide injection by AstraZeneca Pharmaceuticals LP. Visible on the carton are instructions and warnings, with a predominantly teal and white color scheme and a curved, multicolored accent. The vial label matches the product information with readable concentration details and barcode.*
FDA Label Image

Up Facing Arrow (Arrow For Dose Knob)

Up Facing Arrow (Arrow For Dose Knob)
Byetta 250 micrograms per milliliter subcutaneous injection carton and pen injector device. The packaging displays the Byetta brand name prominently, with the active ingredient exenatide indicated. The labeler AstraZeneca Pharmaceuticals LP is shown. The carton and pen injector are designed for prescription use.*
FDA Label Image

Up Facing Arrow (Pushed In Arrow)

Up Facing Arrow (Pushed In Arrow)
Byetta 250 micrograms per milliliter injection package carton. The label shows Byetta brand name and exenatide as the active ingredient. It is a subcutaneous injection provided by AstraZeneca Pharmaceuticals LP. The packaging is primarily white with green and orange elements.*
FDA Label Image

5 (5mcg Window)

5 (5mcg Window)
Byetta 250 micrograms/mL subcutaneous injection carton and vial label showing the product name, strength, injection dosage form, and AstraZeneca Pharmaceuticals LP as the labeler. The packaging is primarily white with black and gray text, including dosage instructions and storage information.*
FDA Label Image

5 (Turn Knob Away Arrow)

5 (Turn Knob Away Arrow)
Byetta 250 mcg/mL injection for subcutaneous use, manufactured by AstraZeneca Pharmaceuticals LP. The image shows a carton box labeled with the proprietary name Byetta and strength 250 mcg/mL.*
FDA Label Image

5 (5mcg Cannot Be Pushed In)

5 (5mcg Cannot Be Pushed In)
Byetta 250 mcg/mL injection, a human prescription drug containing exenatide, is presented in this image. The packaging is for subcutaneous use and labeled by AstraZeneca Pharmaceuticals LP. The image shows a small vial or cartridge container typically used for injection.*
FDA Label Image

Arrow Pointing Up (Arrow In Dose Window Cannot Be Pushed In)

Arrow Pointing Up (Arrow In Dose Window Cannot Be Pushed In)
Byetta 250 mcg/mL injection carton and vial label displaying the product name, active ingredient exenatide, dosage form as injection for subcutaneous use, and the labeler AstraZeneca Pharmaceuticals LP. The carton shows the vial count and concentration, with consistent branding colors and layout.*
FDA Label Image

Arrow Pointing Up (Arrow Knob Wont Turn)

Arrow Pointing Up (Arrow Knob Wont Turn)
Byetta 250 mcg/mL injection label, a subcutaneous human prescription drug by AstraZeneca Pharmaceuticals LP. The label includes drug information, warnings, dosage details, and handling instructions. It features a blue and white design with text highlighting the active ingredient exenatide.*
FDA Label Image

Byetta 10mcg Pen (Image 12)

Byetta 10mcg Pen (Image 12)
Byetta 250 mcg/mL injection pen device for subcutaneous administration is shown. The pen is primarily yellow with a blue cap and end, marked with the number 10 near the dosing window. The device is labeled by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Penparts (Image 13)

Penparts (Image 13)
An instructional diagram showing the parts of a Byetta injection pen for subcutaneous use. The labeled components include the blue pen cap, cartridge containing Byetta liquid, label, dose window, dose knob, and injection button. The diagram is color-coded and titled 'BYETTA PEN PARTS.'*
FDA Label Image

Pen Needle Parts (Image 14)

Pen Needle Parts (Image 14)
Illustration showing parts of a pen needle for injection, including the outer needle shield, inner needle shield, needle, and paper tab. It also explains dose window symbols indicating various stages of dose preparation and injection, such as pulling the dose knob out, turning to the dose position, injecting 10 mcg, and resetting the dose knob.*
FDA Label Image

Figure (Image 15)

Figure (Image 15)
An instructional illustration showing the preparation of Byetta (exenatide) 250 mcg/mL subcutaneous injection. It depicts a person holding the pen injector and a separate cartridge or needle, with arrows indicating how to connect the components before use.*
FDA Label Image

Figure (Image 16)

Figure (Image 16)
An instructional illustration showing a hand holding a yellow injection device for Byetta (exenatide) 250 mcg/mL subcutaneous injection. A blue arrow points to the needle end of the device, indicating part of the injection or preparation process.*
FDA Label Image

Remove Paper (Image 17)

Remove Paper (Image 17)
An instructional diagram illustrating the process of preparing a Byetta (exenatide) 250 mcg/mL injection pen for subcutaneous use. The image shows a hand twisting off a protective yellow cap from the pen, indicating the first step in the injection preparation.*
FDA Label Image

Pull Off Outer (Image 18)

Pull Off Outer (Image 18)
An instructional illustration showing a hand removing a protective cap from a subcutaneous injection pen, demonstrating the preparation step before administering Byetta (exenatide) injection 250 mcg/mL by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Pull Off Inner (Image 19)

Pull Off Inner (Image 19)
An instructional illustration showing a hand removing the protective cap from the needle of a syringe filled with medication. A blue arrow indicates the direction to pull the cap off. The syringe is prefilled and marked with dosage measurements.*
FDA Label Image

Check Arrow (Image 20)

Check Arrow (Image 20)
Byetta 250 mcg/mL injection pen label segment showing dose selector window set at dose number 10. The pen is yellow with a white cap, designed for subcutaneous use. Labeler is AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Pull Dose Knob Out (Image 21)

Pull Dose Knob Out (Image 21)
An instructional illustration showing a close-up of a Byetta injection pen. The image highlights a blue button at the pen's end, with an arrow indicating the action of pressing the button with a thumb, demonstrating part of the injection process for the 250 mcg/mL exenatide subcutaneous injection pen by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Turn Dose Knob (Image 22)

Turn Dose Knob (Image 22)
Instructional diagram showing a finger pressing a yellow Byetta injection pen with a visible blue dosage indicator set to 10. An arrow indicates the direction of pressing to activate or use the injection pen.*
FDA Label Image

Right Facing Arrow (Image 23)

FDA Label Image

Right Facing Arrows (Image 24)

Right Facing Arrows (Image 24)
Byetta 250 mcg/mL injection in a multi-dose pen device with a teal cap. The label includes dosage instructions and AstraZeneca Pharmaceuticals LP as the manufacturer, designed for subcutaneous use.*
FDA Label Image

Up Facing Arrow (Image 25)

Up Facing Arrow (Image 25)
Byetta 250 micrograms per milliliter injection in a prefilled syringe. The carton displays the brand name Byetta and the active ingredient exenatide. The product is labeled for subcutaneous use and is manufactured by AstraZeneca Pharmaceuticals LP. The package appears to contain one prefilled syringe.*
FDA Label Image

10 (Image 26)

10 (Image 26)
Byetta 250 mcg/mL injection label containing exenatide. The label is white with black and red text, including dosage strength and route of administration as subcutaneous injection. Manufactured by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

10 (Image 27)

10 (Image 27)
Byetta 250 mcg/mL injection pen label showing an orange and white design with the proprietary name Byetta prominently displayed. The label includes the active ingredient exenatide, the dosage strength 250 mcg/mL, and the route of administration as subcutaneous injection. The labeler is AstraZeneca Pharmaceuticals LP. The pen is designed for human prescription use.*
FDA Label Image

Point Needle (Image 28)

Point Needle (Image 28)
An instructional illustration showing a hand holding a Byetta injection pen, used for subcutaneous administration. The pen is yellow and white with a clear cap, designed for delivering 250 mcg/mL exenatide dose for human prescription use, manufactured by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Push And Hold (Image 29)

Push And Hold (Image 29)
An instructional illustration showing a hand holding a pen-like injection device with an arrow pointing upward, indicating the direction to hold or move the device. To the right, there is a circular graphic with the text '5 seconds,' likely indicating the recommended injection time or duration for the procedure.*
FDA Label Image

Figure (Image 30)

Figure (Image 30)
Byetta 250 micrograms per milliliter subcutaneous injection cartridge, showing a labeled single cartridge partially enclosed in packaging. The label includes the number '10' in large print on a yellow background and a central area with an arrow symbol within a transparent window. Manufactured by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Triangle3 (Image 31)

Triangle3 (Image 31)
Byetta 250 micrograms/mL injection carton and vial label. The packaging is primarily red, showing the proprietary name Byetta prominently. The dosage form is subcutaneous injection. Labeled by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Turn Knob Away (Image 32)

Turn Knob Away (Image 32)
An instructional illustration showing a close-up of a thumb pressing a blue release button on a Byetta injection pen, labeled with the number 10, indicating dose adjustment or administration technique for the exenatide 250 mcg/mL subcutaneous injection pen by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Right Arrow (Image 33)

Right Arrow (Image 33)
Byetta 250 mcg/mL injection carton and pen injector device shown. The product is a subcutaneous injection of exenatide, labeled by AstraZeneca Pharmaceuticals LP. The packaging is primarily white and blue with the product name and dosage visible on the carton and pen.*
FDA Label Image

Check Pen Label (Image 34)

Check Pen Label (Image 34)
Instructional illustration showing two hands assembling a Byetta injection pen. One hand holds the blue pen cap, the other holds the yellow and blue pen body. A blue arrow indicates the pen cap should be attached to the pen body, demonstrating preparation of the exenatide 250 mcg/mL injection for subcutaneous use.*
FDA Label Image

Check Cartridge (Image 35)

Check Cartridge (Image 35)
An instructional illustration showing hands holding a Byetta 250 mcg/mL injection pen. The image highlights the injection pen with a blue arrow pointing toward the needle cap at the tip, demonstrating preparation or injection technique for subcutaneous use.*
FDA Label Image

Remove Paper Tab (Image 36)

Remove Paper Tab (Image 36)
An instructional illustration showing the assembly of a syringe-like injection device. The image depicts a hand attaching or adjusting a transparent cartridge or component at the end of the device, which features measurement markings and a yellow cap or plunger. This likely demonstrates part of the preparation or use of a subcutaneous injection for the Byetta (exenatide) product.*
FDA Label Image

Pull Off Outer Needle (Image 37)

Pull Off Outer Needle (Image 37)
Instructional illustration showing a close-up of a hand removing a white protective cap from the needle of a syringe pen filled with exenatide injection (Byetta). The syringe pen is purple, indicating a subcutaneous injection device for the 250 mcg/mL strength medication.*
FDA Label Image

Pull Off Inner Needle (Image 38)

Pull Off Inner Needle (Image 38)
An instructional illustration showing a hand placing a purple needle cap onto a syringe. The syringe is intended for subcutaneous injection and is likely related to the Byetta (exenatide) injection product by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Arrow Dose (Image 39)

Arrow Dose (Image 39)
Byetta 250 mcg/mL injection pen showing a close-up of the dose selector window set to 10. The pen is yellow with a clear dose display area and an arrow indicating the dose adjustment. Labeled by AstraZeneca Pharmaceuticals LP for subcutaneous administration.*
FDA Label Image

Pull Knob Unti It Stops (Image 40)

Pull Knob Unti It Stops (Image 40)
An instructional illustration showing how to remove the cap from a Byetta 250 mcg/mL injection pen. The image highlights gripping the pen with one hand and twisting or pulling the white cap with the other hand, indicated by a blue arrow.*
FDA Label Image

Turn Dose Know Away From You (Image 42)

Turn Dose Know Away From You (Image 42)
An instructional illustration showing a finger gripping a pen injector labeled '10' with an arrow indicating a twisting motion, likely demonstrating how to adjust the dose or prepare the injection for the product Byetta (exenatide) 250 mcg/mL injection.*
FDA Label Image

Right Arrow (Image 43)

Right Arrow (Image 43)
Byetta 250 micrograms per milliliter injection in a single-dose vial. The label features the product name and active ingredient exenatide, indicating subcutaneous use. Manufactured by AstraZeneca Pharmaceuticals LP, the design presents dosage information and vial content clearly for prescription use.*
FDA Label Image

Right Arrow (Image 44)

Right Arrow (Image 44)
Byetta 250 mcg/mL injection packaging label for subcutaneous use. The label includes the proprietary name Byetta and notes the active ingredient exenatide. It displays use instructions, AstraZeneca Pharmaceuticals LP as the labeler, and contains detailed prescription drug information on the label.*
FDA Label Image

Uparrow1 (Image 45)

Uparrow1 (Image 45)
Byetta 250 micrograms per milliliter (ug/mL) subcutaneous injection packaging label. The image shows a white and blue carton with the proprietary name Byetta prominently displayed, along with the strength 250 ug/mL. The labeler is AstraZeneca Pharmaceuticals LP. The package is designed for human prescription drug use.*
FDA Label Image

10 (Image 46)

10 (Image 46)
Byetta 250 micrograms per milliliter (ug/mL) injection box by AstraZeneca Pharmaceuticals LP. The packaging is primarily white with purple and blue accents, featuring the Byetta brand name prominently, along with the drug's generic name exenatide, indicating the dosage strength and injection form for subcutaneous use.*
FDA Label Image

10 (Image 47)

10 (Image 47)
Byetta 250 mcg/mL injection in a prefilled pen device, labeled for subcutaneous use. The product contains exenatide as the active ingredient and is manufactured by AstraZeneca Pharmaceuticals LP. The label includes dosage strength and administration instructions visible on the pen.*
FDA Label Image

Grip Pen (Image 48)

Grip Pen (Image 48)
An instructional illustration showing a person administering a subcutaneous injection into the abdomen using a pen injector device. The injection pen is labeled with yellow and blue colors, consistent with Byetta (exenatide) 250 mcg/mL injection by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Push Injection (Image 49)

Push Injection (Image 49)
An instructional illustration showing a person holding a Byetta injection pen labeled with the number 10. The image highlights a step involving pressing a blue button or cap, with a circular icon indicating to hold for 5 seconds, likely illustrating part of the injection process for Byetta 250 mcg/mL subcutaneous injection by AstraZeneca Pharmaceuticals.*
FDA Label Image

Injection Complete (Image 50)

Injection Complete (Image 50)
The image shows a Byetta 250 mcg/mL subcutaneous injection pen. The visible portion includes the dosage window with a numeric indicator '10', suggesting a dose or unit display on the pen device. The product is by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Triangle5 (Image 55)

Triangle5 (Image 55)
Byetta 250 mcg/mL injection carton label showing the product name Byetta with the active ingredient exenatide. The label indicates it is a human prescription drug indicated for subcutaneous injection. The labeler is AstraZeneca Pharmaceuticals LP. The carton design includes blue and purple color elements.*
FDA Label Image

Turn Knob Away Until It Stops (Image 57)

Turn Knob Away Until It Stops (Image 57)
An instructional diagram showing a close-up of a finger pressing a blue button on a yellow injector pen labeled with the number 10, demonstrating the injection technique or device usage for Byetta (exenatide) 250 mcg/mL subcutaneous injection by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Right Arrow (Image 58)

Right Arrow (Image 58)
Byetta 250 microgram per milliliter injection for subcutaneous use. The packaging shows a green and black box with white text, featuring the brand name Byetta prominently along with its generic name exenatide. The labeler AstraZeneca Pharmaceuticals LP is identified.*
FDA Label Image

Cover Needle (Image 59)

Cover Needle (Image 59)
An instructional illustration showing a Byetta injection pen with a cap being removed, indicated by a blue arrow pointing away from the pen. The pen is yellow and white, designed for subcutaneous injection of exenatide at 250 mcg/mL strength by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Unscrew (Image 60)

Unscrew (Image 60)
Instructional illustration showing a Byetta 250 mcg/mL subcutaneous injection pen held by a hand. The image depicts the technique for administering the injection using the pen device.*
FDA Label Image

Throw Away Needle (Image 61)

Throw Away Needle (Image 61)
Byetta 250 mcg/mL subcutaneous injection packaging labeled with AstraZeneca Pharmaceuticals LP as the labeler. The image shows a hand opening or placing something into the red-yellow container designed for safe disposal of sharps or needles associated with the injection product.*
FDA Label Image

Triangle4 (Image 62)

FDA Label Image

Where To Inject Byetta (Image 63)

Where To Inject Byetta (Image 63)
An illustration showing recommended injection sites for Byetta (exenatide) injection. The front view highlights the abdomen and thigh areas, while the back view emphasizes the upper arm as injection locations for subcutaneous administration.*
FDA Label Image

Rightarrow2 (Image 64)

Rightarrow2 (Image 64)
Byetta 250 mcg/mL injection in a 5-mL single-use vial. The label shows the proprietary name Byetta and the strength 250 mcg/mL, indicating it is for subcutaneous use. The labeler AstraZeneca Pharmaceuticals LP is noted on the vial label.*
FDA Label Image

Plus Sign (Image 65)

Plus Sign (Image 65)
Byetta 250 mcg/mL injection pen label for subcutaneous use. The label features the proprietary name Byetta prominently and specifies exenatide as the active ingredient. The label indicates the dosage form as an injection, and it is manufactured by AstraZeneca Pharmaceuticals LP. The label is white with black and red text, including dosage strength and important usage information.*
FDA Label Image

Plus Sign (Image 66)

Plus Sign (Image 66)
Byetta 250 mcg/mL injection carton and vial label for subcutaneous use. The packaging shows the brand name Byetta and indicates the active ingredient exenatide. The labeler is AstraZeneca Pharmaceuticals LP. The image includes a 5 mL vial and a printed carton with prescribing information visible.*
FDA Label Image

Pushed In Arrow (Image 67)

Pushed In Arrow (Image 67)
Byetta 250 micrograms per milliliter injection in a prefilled pen device by AstraZeneca Pharmaceuticals LP. The injection pen is white with a label showing the product name and strength, designed for subcutaneous use.*
FDA Label Image

10 (Image 68)

10 (Image 68)
Byetta 250 mcg/mL injection label for subcutaneous use showing proprietary name Byetta and generic name exenatide. The label features dosage strength 250 mcg/mL and indicates it is a human prescription drug. The labeler is AstraZeneca Pharmaceuticals LP. The design includes blue and black text on a white background with a small blue and green logo.*
FDA Label Image

10 (Image 69)

10 (Image 69)
Byetta 250 mcg/mL injection, which contains the active ingredient exenatide, is presented in a box labeled for subcutaneous use. The packaging prominently displays the proprietary name Byetta, strength 250 mcg/mL, dosage form injection, and the labeler AstraZeneca Pharmaceuticals LP.*
FDA Label Image

10 (Image 70)

10 (Image 70)
Byetta 250 mcg/mL injection single-dose pen label in blue and white, showing the AstraZeneca Pharmaceuticals LP logo. The label includes proprietary and nonproprietary names, dosage form, strength, and subcutaneous route, with instructions and warnings visible.*
FDA Label Image

Up Arrow (Image 71)

Up Arrow (Image 71)
Byetta 250 mcg/mL injection carton from AstraZeneca Pharmaceuticals LP, designed for subcutaneous use. The packaging features the brand name prominently with dosage strength. Background incorporates yellow and red elements with product information displayed clearly.*
FDA Label Image

Up Arrow (Image 72)

Up Arrow (Image 72)
Byetta 250 microgram per milliliter injection carton and single-use prefilled pen device. The outer box and pen are shown with blue and white color scheme, displaying the AstraZeneca Pharmaceuticals LP labeler name. The injection is intended for subcutaneous use.*
FDA Label Image

Rarrow (Rarrow)

Rarrow (Rarrow)
Byetta 250 mcg/mL injection in a single-use pen injector device. The image shows a clear pen with a black label band near the plunger end and a transparent cap covering the needle end. The label includes the brand name Byetta and indicates it is for subcutaneous injection. The manufacturer AstraZeneca Pharmaceuticals LP is not visible on the device but noted in product data.*
FDA Label Image

5mcg (Image 01)

5mcg (Image 01)
Byetta 250 mcg/mL subcutaneous injection prefilled pen label. The label shows a single-use pen delivering doses of 5 mcg each, with a 1.2 mL volume. It includes warnings for refrigeration, disposal instructions, and notes that pen needles are not included. The product is by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

10mcg (Byetta 70)

10mcg (Byetta 70)
Byetta 250 mcg/mL injection label showing a prefilled pen delivering 10 mcg per dose with 60 doses per pen. The label indicates subcutaneous use, refrigeration requirements, and that the pen needles are not included. The product is by AstraZeneca Pharmaceuticals LP for single patient use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.